Surbhi Sidana, MD | Stanford Medicine

Dr. Surbhi Sidana, MD

Claim this profile

Stanford University

Studies Non-Hodgkin's Lymphoma
Studies Mixed-Cell Lymphoma
5 reported clinical trials
9 drugs studied

Area of expertise

1

Non-Hodgkin's Lymphoma

Surbhi Sidana, MD has run 3 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:

Philadelphia Chromosome positive
CD22 positive
CD22 negative
2

Mixed-Cell Lymphoma

Surbhi Sidana, MD has run 2 trials for Mixed-Cell Lymphoma. Some of their research focus areas include:

CD19 positive

Affiliated Hospitals

Image of trial facility.

Stanford University

Image of trial facility.

Stanford Medical Center

Clinical Trials Surbhi Sidana, MD is currently running

More about Surbhi Sidana, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Surbhi Sidana, MD has experience with

  • Cyclophosphamide
  • Biostrap Arm Band
  • CD22 CAR
  • Fludarabine
  • CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells
  • Fludarabine Phosphate

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Surbhi Sidana, MD specialize in?

Is Surbhi Sidana, MD currently recruiting for clinical trials?

Are there any treatments that Surbhi Sidana, MD has studied deeply?

What is the best way to schedule an appointment with Surbhi Sidana, MD?

What is the office address of Surbhi Sidana, MD?

Is there any support for travel costs?